MDC1 inhibitors belong to a distinct chemical class that holds significance in various biological processes within the context of cellular responses to DNA damage. MDC1, or mediator of DNA damage checkpoint protein 1, plays a pivotal role in the orchestration of DNA damage repair and the activation of cell cycle checkpoints. The inhibitors targeting MDC1 operate by selectively impeding its function, which involves acting as a scaffold for recruiting key DNA damage response factors to the sites of DNA lesions. Structurally, MDC1 inhibitors are designed to interact with specific binding pockets or domains of the MDC1 protein, thereby disrupting its protein-protein interactions critical for its recruitment role. This interference subsequently influences downstream signaling cascades involved in DNA repair pathways. The development and utilization of MDC1 inhibitors have significantly contributed to the enhanced understanding of the intricate machinery behind DNA damage repair processes. Researchers have employed these inhibitors as valuable tools in deciphering the precise sequence of events and molecular players in DNA damage response pathways. Through the selective inhibition of MDC1, researchers have been able to dissect the temporal and spatial dynamics of DNA damage signaling, uncovering the nuances of how cells sense and repair DNA lesions. Furthermore, these inhibitors have facilitated investigations into the crosstalk between different DNA repair pathways and the coordination of cellular responses to various types of genotoxic stress.
In summary, MDC1 inhibitors represent a distinctive class of compounds that play a vital role in advancing our comprehension of DNA damage repair mechanisms. Their specificity in targeting MDC1 has unveiled intricate details about the coordination of DNA damage response pathways, shedding light on the underlying processes that maintain genomic stability. By disrupting MDC1-mediated protein interactions and subsequent signaling events, these inhibitors have become indispensable tools for researchers aiming to unravel the complexities of cellular responses to DNA damage.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
A small molecule inhibitor known to target ATM (Ataxia Telangiectasia Mutated) kinase, which is a key upstream regulator of the DNA damage response. This indirectly affects MDC1's function. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $357.00 | 10 | |
Another ATM inhibitor that might indirectly affect MDC1 function in DNA repair pathways. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
This inhibitor targets the ATR (Ataxia Telangiectasia and Rad3-related) kinase, which is involved in another branch of DNA damage response. MDC1 might interact with ATR-mediated pathways. | ||||||
MRN-ATM Pathway Inhibitor, Mirin | 299953-00-7 | sc-203144 | 10 mg | $141.00 | 4 | |
An inhibitor of Mre11, a component of the MRN complex involved in DNA damage sensing and repair. MDC1 interacts with the MRN complex. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound found in turmeric, curcumin has been explored for its potential in inhibiting various pathways involved in cancer development, which could indirectly affect MDC1-related pathways. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
This inhibitor targets both CHK1 and CHK2 kinases, which are involved in cell cycle checkpoint regulation. MDC1's functions might intersect with these pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Although primarily a JNK (c-Jun N-terminal kinase) inhibitor, SP600125 might impact DNA repair and damage response pathways that MDC1 participates in. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $106.00 | 8 | |
This compound targets CK1 (casein kinase 1) isoforms and might indirectly influence MDC1-associated pathways. | ||||||